Related Experiment Video
Updated: Aug 3, 2026

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Autoimmunity and ALS
R G Smith1, L Siklos, M E Alexianu
1Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
Neurology
|October 1, 1996
Summary
Antibodies targeting voltage-gated calcium channels in sporadic ALS (SALS) disrupt neuromuscular junctions and cause cell death. These findings suggest a potential autoimmune link in SALS pathogenesis.
Area of Science:
- Neuroimmunology
- Ion Channelopathies
- Motor Neuron Diseases
Background:
- Autoantibodies against voltage-gated calcium channels (VGCCs) are found in some sporadic amyotrophic lateral sclerosis (SALS) patients.
- These antibodies can alter VGCC function in vitro and in vivo.
Purpose of the Study:
- To investigate the role of VGCC antibodies in SALS pathogenesis.
- To explore the mechanisms by which these antibodies affect motor neurons.
Main Methods:
- Passive transfer of human SALS immunoglobulin fractions into mice.
- In vitro studies using a differentiated motor neuron hybrid cell line.
- Analysis of neuromuscular junction alterations and intracellular calcium homeostasis.
- Assessment of apoptosis and oxidative injury.
Main Results:
- Passive transfer of SALS immunoglobulins induced neuromuscular junction changes similar to those in SALS patients.
- SALS immunoglobulins triggered calcium-dependent apoptosis in motor neurons via oxidative injury.
- Apoptosis was regulated by calcium-binding proteins, potentially influencing motor neuron vulnerability.
Conclusions:
- Antibodies to VGCCs may contribute to SALS pathogenesis by disrupting neuromuscular function and inducing motor neuron apoptosis.
- Oxidative injury and calcium dysregulation are key mechanisms in SALS immunoglobulin-mediated neurotoxicity.
- Calcium-binding proteins may play a role in selective motor neuron vulnerability in SALS.
Related Concept Videos
What is the Immune System?
Overview
Cell-mediated Immune Responses
Overview
Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

